Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
NCOA4 encodes an androgen receptor coactivator. Additionally we are shipping NCOA4 Proteins (6) and many more products for this protein.
Showing 10 out of 74 products:
Human Polyclonal NCOA4 Primary Antibody for EIA, WB - ABIN953616
Sadow, Heinrich, Corless, Fletcher, Nosé: Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas. in Endocrine pathology 2010
Show all 2 references for ABIN953616
Human Monoclonal NCOA4 Primary Antibody for IF, ELISA - ABIN521736
Poola, Abraham, Marshalleck, Yue, Fu, Viswanath, Sharma, Hill, Dewitty, Bonney: Molecular constitution of breast but not other reproductive tissues is rich in growth promoting molecules: a possible link to highest incidence of tumor growths. in FEBS letters 2009
NCOA4 acts as a regulator of DNA replication origins that helps prevent inappropriate DNA synthesis and replication stress.
Ubiquitin-dependent NCOA4 turnover is promoted by excess iron and involves an iron-dependent interaction between NCOA4 and the HERC2 ubiquitin ligase.
Studies indicate nuclear receptor coactivator 4 (NcoA4) as a coactivator for a variety of nuclear receptors.
provide a new mechanism for selective autophagy of ferritin (show FTL Antibodies) and reveal a previously unappreciated role for autophagy and NCOA4 in the control of iron homeostasis in vivo
RET (show RET Antibodies)/PTC3 gene rearrangements are the most prevalent form of rearrangements in papillary thyroid carcinomas of Chennai population.
identification of NCOA4 as a selective cargo receptor for autophagic turnover of ferritin (show FTL Antibodies) (ferritinophagy), which is critical for iron homeostasis, and provides a resource for further dissection of autophagosomal cargo-receptor connectivity
mechanism dissection shows that KLK2 (show KLK2 Antibodies) may cooperate with the AR coregulator, ARA70, to enhance AR transactivation that may result in alteration of prostate cancer formation
Data indicate that the increase in prostate cancer (PC) risk associated with rs10993994:C>T is likely mediated by the variant's effect of MSMB (show MSMB Antibodies)-encoded protein PSP94 (show MSMB Antibodies) expression; however, this effect does not extend to NCOA4 in the data.
Computational network analysis reveals that the MSMB (show MSMB Antibodies) gene is functionally connected to NCOA4 and the androgen receptor (show AR Antibodies) signaling pathway. The data provide an example of how GWAS-associated variants may have multiple genetic and epigenetic effects
Suppression of MSMB (show MSMB Antibodies) expression or NCOA4 overexpression promotes anchorage-independent growth of prostate epithelial cells.
Results demonstrate ubiquitous NcoA4 expression throughout development and suggest that this coactivator may play a role in modulating nuclear receptor activity, particularly that of the aryl hydrocarbon receptor (show AHR Antibodies), during development.
Data suggest that myostatin (show MSTN Antibodies) decreases the activity of androgen receptors (AR) by down-regulating the expression of ARA70, a known stimulating co-factor of AR
This gene encodes an androgen receptor coactivator. The encoded protein interacts with the androgen receptor in a ligand-dependent manner to enhance its transcriptional activity. Chromosomal translocations between this gene and the ret tyrosine kinase gene, also located on chromosome 10, have been associated with papillary thyroid carcinoma. Alternatively spliced transcript variants have been described. Pseudogenes are present on chromosomes 4, 5, 10, and 14.
nuclear receptor coactivator 4
, Nuclear receptor coactivator 4
, 70 kDa AR-activator
, 70 kDa androgen receptor coactivator
, RET-activating gene ELE1
, androgen receptor-associated protein of 70 kDa
, ret fused